Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement [Yahoo! Finance]
KalVista Pharmaceuticals, Inc. (KALV)
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.kalvista.com
Company Research
Source: Yahoo! Finance
higher after news that Italy's Chiesi Group will acquire KalVista for $27 per share in cash. Investors are watching deal closing risks and regulatory approvals. Trading volume reached 69.4 million shares, about 3,323% above its three-month average of 2 million shares. KalVista Pharmaceuticals IPO'd in 2015 and has fallen 66% since going public. How the markets moved today The S&P 500 slipped 0.02% to finish Wednesday at 7,138, while the Nasdaq Composite inched up 0.04% to close at 24,673. Within the biotechnology sector , rivals were mixed, with Prothena closing at $10.87, down 5.56%, as investors reassessed risk around drug pipelines and deal activity. What this means for investors KalVista Pharmaceuticals' stock is pricing in a high likelihood that the company will be taken private by Italy's Chiesi Group at $27 per share, after its share price spiked 39% today to $26.67. Home to EKTERLY, an oral medicine for hereditary angioedema, which affects 1 in 50,000 people, KalVista'
Show less
Read more
Impact Snapshot
Event Time:
KALV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KALV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KALV alerts
High impacting KalVista Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
KALV
News
- Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- KalVista: 'Strong Buy' As Acquired By Chiesi And Positive KONFIDENT-KID Outcome [Seeking Alpha]Seeking Alpha
- Shareholder Alert: Ademi LLP investigates whether KalVista Pharmaceuticals Inc. is obtaining a Fair Price for Public ShareholdersPR Newswire
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of KalVista Pharmaceuticals, Inc. (NASDAQ: KALV)GlobeNewswire
- KALV Stock Alert: Halper Sadeh LLC is Investigating Whether KalVista Pharmaceuticals, Inc. is Obtaining a Fair Price for its ShareholdersBusiness Wire
KALV
Earnings
- 3/25/26 - Miss
KALV
Sec Filings
- 4/29/26 - Form SC14D9C
- 4/29/26 - Form 8-K
- 4/20/26 - Form 4
- KALV's page on the SEC website